Logo image of SRI

STONERIDGE INC (SRI) Stock Fundamental Analysis

NYSE:SRI - New York Stock Exchange, Inc. - US86183P1021 - Common Stock - Currency: USD

4.75  -0.06 (-1.25%)

After market: 4.75 0 (0%)

Fundamental Rating

3

Taking everything into account, SRI scores 3 out of 10 in our fundamental rating. SRI was compared to 81 industry peers in the Automobile Components industry. SRI may be in some trouble as it scores bad on both profitability and health. SRI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SRI has reported negative net income.
In the past year SRI had a positive cash flow from operations.
SRI had negative earnings in 4 of the past 5 years.
SRI had a positive operating cash flow in 4 of the past 5 years.
SRI Yearly Net Income VS EBIT VS OCF VS FCFSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SRI's Return On Assets of -2.68% is on the low side compared to the rest of the industry. SRI is outperformed by 80.25% of its industry peers.
Looking at the Return On Equity, with a value of -6.95%, SRI is doing worse than 77.78% of the companies in the same industry.
SRI's Return On Invested Capital of 0.25% is on the low side compared to the rest of the industry. SRI is outperformed by 82.72% of its industry peers.
SRI had an Average Return On Invested Capital over the past 3 years of 1.22%. This is significantly below the industry average of 9.05%.
Industry RankSector Rank
ROA -2.68%
ROE -6.95%
ROIC 0.25%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)1.22%
ROIC(5y)N/A
SRI Yearly ROA, ROE, ROICSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

With a Operating Margin value of 0.17%, SRI is not doing good in the industry: 82.72% of the companies in the same industry are doing better.
SRI's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 21.33%, SRI is doing worse than 69.14% of the companies in the same industry.
In the last couple of years the Gross Margin of SRI has declined.
Industry RankSector Rank
OM 0.17%
PM (TTM) N/A
GM 21.33%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
SRI Yearly Profit, Operating, Gross MarginsSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

SRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SRI has more shares outstanding than it did 1 year ago.
SRI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SRI has a worse debt to assets ratio.
SRI Yearly Shares OutstandingSRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SRI Yearly Total Debt VS Total AssetsSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.36 indicates that SRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.36, SRI perfoms like the industry average, outperforming 50.62% of the companies in the same industry.
The Debt to FCF ratio of SRI is 8.14, which is on the high side as it means it would take SRI, 8.14 years of fcf income to pay off all of its debts.
SRI has a worse Debt to FCF ratio (8.14) than 67.90% of its industry peers.
SRI has a Debt/Equity ratio of 0.80. This is a neutral value indicating SRI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.80, SRI is doing worse than 82.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.14
Altman-Z 2.36
ROIC/WACC0.03
WACC9.9%
SRI Yearly LT Debt VS Equity VS FCFSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

SRI has a Current Ratio of 2.39. This indicates that SRI is financially healthy and has no problem in meeting its short term obligations.
SRI has a Current ratio of 2.39. This is in the better half of the industry: SRI outperforms 79.01% of its industry peers.
A Quick Ratio of 1.52 indicates that SRI should not have too much problems paying its short term obligations.
The Quick ratio of SRI (1.52) is better than 82.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.52
SRI Yearly Current Assets VS Current LiabilitesSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

SRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -264.29%.
The Revenue has decreased by -8.90% in the past year.
Measured over the past years, SRI shows a small growth in Revenue. The Revenue has been growing by 1.71% on average per year.
EPS 1Y (TTM)-264.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)-8.9%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-8.89%

3.2 Future

Based on estimates for the next years, SRI will show a very strong growth in Earnings Per Share. The EPS will grow by 67.19% on average per year.
SRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.99% yearly.
EPS Next Y31.23%
EPS Next 2Y67.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.73%
Revenue Next 2Y2.99%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SRI Yearly Revenue VS EstimatesSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
SRI Yearly EPS VS EstimatesSRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRI. In the last year negative earnings were reported.
SRI is valuated correctly with a Price/Forward Earnings ratio of 12.71.
SRI's Price/Forward Earnings ratio is in line with the industry average.
SRI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 12.71
SRI Price Earnings VS Forward Price EarningsSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

SRI's Enterprise Value to EBITDA is on the same level as the industry average.
SRI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SRI is cheaper than 86.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.3
EV/EBITDA 7.27
SRI Per share dataSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SRI's earnings are expected to grow with 67.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.19%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STONERIDGE INC

NYSE:SRI (5/23/2025, 8:57:02 PM)

After market: 4.75 0 (0%)

4.75

-0.06 (-1.25%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners97.94%
Inst Owner Change7.67%
Ins Owners2.41%
Ins Owner Change9.46%
Market Cap132.29M
Analysts86.67
Price Target14.28 (200.63%)
Short Float %1.71%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-196.74%
Min EPS beat(2)-345.54%
Max EPS beat(2)-47.95%
EPS beat(4)1
Avg EPS beat(4)37.77%
Min EPS beat(4)-397.03%
Max EPS beat(4)941.58%
EPS beat(8)4
Avg EPS beat(8)26.56%
EPS beat(12)6
Avg EPS beat(12)30.03%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-2.68%
Max Revenue beat(2)2.92%
Revenue beat(4)1
Avg Revenue beat(4)-2.7%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)2.92%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)7
Avg Revenue beat(12)2.18%
Revenue beat(16)10
Avg Revenue beat(16)3.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)28%
EPS NQ rev (3m)-1000%
EPS NY rev (1m)18.37%
EPS NY rev (3m)-420%
Revenue NQ rev (1m)1.19%
Revenue NQ rev (3m)-6.12%
Revenue NY rev (1m)1.66%
Revenue NY rev (3m)-6.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.71
P/S 0.15
P/FCF 5.3
P/OCF 2.67
P/B 0.52
P/tB 0.75
EV/EBITDA 7.27
EPS(TTM)-0.51
EYN/A
EPS(NY)0.37
Fwd EY7.87%
FCF(TTM)0.9
FCFY18.87%
OCF(TTM)1.78
OCFY37.45%
SpS31.85
BVpS9.09
TBVpS6.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.68%
ROE -6.95%
ROCE 0.32%
ROIC 0.25%
ROICexc 0.3%
ROICexgc 0.37%
OM 0.17%
PM (TTM) N/A
GM 21.33%
FCFM 2.81%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)1.22%
ROIC(5y)N/A
ROICexc(3y)1.34%
ROICexc(5y)N/A
ROICexgc(3y)1.64%
ROICexgc(5y)N/A
ROCE(3y)1.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-44.52%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.72%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.14
Debt/EBITDA 5.77
Cap/Depr 72.91%
Cap/Sales 2.77%
Interest Coverage 0.11
Cash Conversion 140.56%
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 1.52
Altman-Z 2.36
F-Score4
WACC9.9%
ROIC/WACC0.03
Cap/Depr(3y)90.27%
Cap/Depr(5y)89.37%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-264.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y31.23%
EPS Next 2Y67.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.9%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-8.89%
Revenue Next Year-3.73%
Revenue Next 2Y2.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.51%
EBIT growth 3YN/A
EBIT growth 5Y-43.57%
EBIT Next Year178.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y247.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y184.12%
OCF growth 3YN/A
OCF growth 5Y14.27%